BioLineRx Ltd (BLRX) — Working Capital to Net Assets Ratio
BioLineRx Ltd (BLRX) has a Working Capital to Net Assets ratio of 49.5% as of December 2025. Working capital of $11.56 Million (current assets of $23.68 Million minus current liabilities of $12.12 Million) is measured against net assets of $23.34 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BLRX net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BioLineRx Ltd Working Capital to Net Assets (2008–2025)
This chart shows how BioLineRx Ltd's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 49.5%, reflecting working capital of $11.56 Million against net assets of $23.34 Million USD. Check BLRX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for BioLineRx Ltd (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is BioLineRx Ltd worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.5% | $11.56 Million | $23.34 Million | $23.68 Million | $12.12 Million | ▼ -37.4 pp |
| 2024 | 86.9% | $11.70 Million | $13.46 Million | $27.10 Million | $15.41 Million | ▲ +53.6 pp |
| 2023 | 33.3% | $4.40 Million | $13.22 Million | $47.18 Million | $42.78 Million | ▼ -48.0 pp |
| 2022 | 81.3% | $41.32 Million | $50.84 Million | $52.00 Million | $10.68 Million | ▲ +11.2 pp |
| 2021 | 70.0% | $47.69 Million | $68.09 Million | $57.40 Million | $9.72 Million | ▲ +14.5 pp |
| 2020 | 55.6% | $12.24 Million | $22.03 Million | $22.88 Million | $10.64 Million | ▲ +6.9 pp |
| 2019 | 48.7% | $16.24 Million | $33.38 Million | $28.21 Million | $11.97 Million | ▼ -12.4 pp |
| 2018 | 61.1% | $25.23 Million | $41.32 Million | $31.98 Million | $6.75 Million | ▼ -21.5 pp |
| 2017 | 82.6% | $43.65 Million | $52.88 Million | $50.38 Million | $6.72 Million | ▼ -10.1 pp |
| 2016 | 92.6% | $32.44 Million | $35.03 Million | $36.10 Million | $3.66 Million | ▼ -2.0 pp |
| 2015 | 94.6% | $45.04 Million | $47.61 Million | $48.18 Million | $3.14 Million | ▼ -6.8 pp |
| 2014 | 101.4% | $32.21 Million | $31.77 Million | $35.11 Million | $2.90 Million | ▼ -33.2 pp |
| 2013 | 134.6% | $15.72 Million | $11.68 Million | $18.77 Million | $3.05 Million | ▲ +29.3 pp |
| 2012 | 105.2% | $15.75 Million | $14.97 Million | $22.18 Million | $6.43 Million | ▲ +14.7 pp |
| 2011 | 90.5% | $20.40 Million | $22.53 Million | $27.16 Million | $6.75 Million | ▼ -3.4 pp |
| 2010 | 93.9% | $35.00 Million | $37.26 Million | $41.27 Million | $6.27 Million | ▲ +4.2 pp |
| 2009 | 89.7% | $27.93 Million | $31.13 Million | $38.82 Million | $10.88 Million | ▲ +6.5 pp |
| 2008 | 83.2% | $17.27 Million | $20.75 Million | $27.15 Million | $9.88 Million | — |